BioMarin outlines $3.825B-$3.925B 2026 revenue outlook driven by Amicus integration and 20% growth target
BioMarin Pharmaceuticals Inc · PHARMACEUTICAL PREPARATIONS · Now $57.29
+2.6% in 1d after detection
Post-detection moves
1h
—
1d
+2.6%
3d
+1.5%
7d
0.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS